Perspective Therapeutics, Inc.

NYSEAM:CATX Stock Report

Market Cap: US$170.3m

Perspective Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:CATX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Dec 24BuyUS$30,132Johan SpoorIndividual8,000US$3.77
04 Dec 24BuyUS$100,004Heidi HensonIndividual25,975US$3.85
25 Nov 24BuyUS$48,974Jonathan HuntIndividual12,829US$3.94
17 Jun 24BuyUS$17,667Jonathan HuntIndividual1,800US$9.82
14 Jun 24BuyUS$499,900Lori Holmes-WoodsIndividual4,587US$109.00
13 Jun 24BuyUS$117,430Johan SpoorIndividual10,000US$11.74
03 Jun 24BuyUS$49,992Lori Holmes-WoodsIndividual3,424.6US$14.60
31 May 24BuyUS$75,900Robert WilliamsonIndividual5,500US$13.80
31 May 24BuyUS$35,007Jonathan HuntIndividual2,500.6US$14.00
29 May 24BuyUS$40,014Robert WilliamsonIndividual3,003.1US$13.40

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CATX?
Owner TypeNumber of SharesOwnership Percentage
General Public36,2320.0536%
Individual Insiders3,469,2985.13%
Private Companies4,343,0996.43%
Public Companies11,677,33917.3%
Institutions48,061,57271.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.2%.

Top Shareholders

Top 25 shareholders own 86.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.3%
Lantheus Holdings, Inc.
11,677,339US$29.4m0%no data
14.8%
FMR LLC
10,027,301US$25.3m82.2%no data
6.07%
BlackRock, Inc.
4,105,247US$10.3m1.62%no data
4.65%
The Vanguard Group, Inc.
3,144,867US$7.9m2.21%no data
4.35%
Deerfield Management Company, L.P. Series C
2,938,754US$7.4m4.29%0.15%
3.99%
Avidity Partners Management, L.P.
2,694,600US$6.8m-25%0.72%
3.99%
ASV-Viewpoint LLC
2,693,387US$6.8m0%no data
3.41%
Octagon Capital Advisors LP
2,304,752US$5.8m62%1.08%
2.44%
Coleman 2022 Exempt Family Trust
1,649,712US$4.2m0%no data
2.38%
Nicholson Wealth Management Group, LLC
1,609,283US$4.1m0.44%2.64%
2.19%
Frances Johnson
1,483,466US$3.7m0%no data
2.19%
Michael Schultz
1,483,466US$3.7m0%no data
1.92%
Affinity Asset Advisors, LLC
1,300,000US$3.3m160%0.61%
1.92%
Millennium Management LLC
1,295,343US$3.3m0%no data
1.76%
Perceptive Advisors LLC
1,190,263US$3.0m0%0.08%
1.73%
Geode Capital Management, LLC
1,167,428US$2.9m0.28%no data
1.68%
Morgan Stanley, Investment Banking and Brokerage Investments
1,137,528US$2.9m301%no data
1.64%
State Street Global Advisors, Inc.
1,108,193US$2.8m-49.4%no data
1.52%
Hills Bank and Trust Company, Asset Management Arm
1,027,830US$2.6m0%0.19%
1.32%
Goldman Sachs Group, Investment Banking and Securities Investments
892,565US$2.2m113%no data
1.19%
Marshall Wace LLP
807,172US$2.0m-45.9%no data
1.11%
Ghost Tree Capital, LLC
750,000US$1.9m0%0.83%
1.06%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
714,306US$1.8m-13.2%no data
0.96%
Two Sigma Investments, LP
650,351US$1.6m0%no data
0.95%
UBS Asset Management AG
641,898US$1.6m342%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/23 10:01
End of Day Share Price 2025/03/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Perspective Therapeutics, Inc. is covered by 15 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Alec StranahanBofA Global Research
Yuan ZhiB. Riley Securities, Inc.